Home Up Call me back Contents Contact Immunology / Infectious agents / Cellular Biology / Molecular biology / Instruments / Lentiviral Technology / RNAi Libreries / Stem Cell Research / MicroRNA / Proteomics / Chemicals / Campaign / Antibodies Myeloperoxidase Detection 

Google

       Pricelist 2010 

Home
Up

redcoon België GENTAUR BVBA

VAT BE0473327336

Av. de l Armee 68 B4

1040 Brussels BELGIUM

  Tel + 32 16 58 90 45 

Fax + 32 16 50 90 45

GENTAUR France SARL

SIRET 48423788800017

Rue Lagrange, 9

75005 Paris, France

 Tel 01 43 25 01 50

Fax 01 43 25 01 60 

GENTAUR Germany

52074 Aachen, Germany

 Tel 0241 40 08 90 86

Fax 0241 55 91 05 36

GENTAUR Pol Sp. Z.o.o. Ulica Ogarna 15/19B m2

80-826 GDANSK

Tel 00 48 51 760 77 08

Fax: 00 32 16 50 90 45

GENTAUR Italy

23015 Milano, Italy

 Tel 02 36 00 65 93

Fax 02 36 00 65 94

Česká republika Praha
+420246019719
 

Danmark

+4569918806 

Finland Helsset
+358942419041

Ελλάς Αθήνα
+302111768494
 

Ireland Dublin
+35316526556
 

Luxembourg
+35220880274
 

Magyarország Budapest
+3619980547
 

Nederland
+31208080893
 

Norge Oslo
+4721031366
 

Österreich
+43720880899
 

Sverige Stockholm
+46852503438
 

Schweiz Züri
+41435006251
 

 

Northern America 

Canada Montreal
+15149077481
 

US New York
+17185132983

 

Other Countries redcoon België
0032 (0)16 41 44 07

 

LINEAR NF-κB Decoy Oligonucleotides Kits and RIBBON NF-κB Decoy Oligonucleotides Kits

Background: 

Painful inflammatory diseases such as rheumatoid arthritis and atopic dermatitis are currently treated primarily symptomatically, through the use of analgesics. Thus, there is a great need for novel therapeutics targeting the underlying inflammatory mechanisms. NF-κB is an intensively studied transcription factor well known for its role in stimulating the production of inflammatory cytokines. Recently, NF-κB decoy nucleic acids have gained considerable attention as potential therapeutics for inflammatory disease due to their ability to inhibit NFκB-mediated production of inflammatory cytokines, by preventing NF-κB from binding to its native DNA binding sites. Preliminary studies with NF-κB decoys indicate efficacy in reducing both pain and itch.

First generation NF-κB decoy nucleic acid drugs were linear DNA duplexes. Such drugs suffered not only from poor cellular uptake, but also from serum half-life due to poor resistance to nucleases. Subsequently, a circular (ribbon) form of NF-κB decoy was developed with improved nuclease resistance and significantly longer half-life.

Kit component: 

Offered here are NF-κB decoy oligodeoxynucleotides kits for our own research. Each kit contains the specified oligo and a control oligo with an identical base composition but different sequence that does not bind NF-κB. Phosphorotioate-modified kits are also offered. Please see the individual product datasheets for exact specifications. All oligos are purified by HPLC

_________________________________________________________________________________________________________________________

RIBBON NFκB Decoy Oligonucleotides Kit GDS-DN-25101 2*0.5 MG €600
RIBBON NFκB Decoy Oligonucleotides Kit GDS-DN-25102 2*0.5 MG €677
NFκB decoy Oligonucleotides Kit GDS-DN-15101 2*1 MG €447
NFκB decoy Oligonucleotides Kit GDS-DN-15102 2*1 MG €524
NFκB decoy Oligonucleotides Kit GDS-DN-15103 2*1 MG €485